E

Emcure Pharmaceuticals Ltd
NSE:EMCURE

Watchlist Manager
Emcure Pharmaceuticals Ltd
NSE:EMCURE
Watchlist
Price: 937.45 INR -5.06% Market Closed
Market Cap: 177.6B INR
Financials Section:
Income Statement Balance Sheet Cash Flow Statement

Income Statement

0
Revenue
+0%
Dec 31, 2024 124.4B
Sep 30, 2024 104.8B
0
Operating Income
+0%
Dec 31, 2024 17B
Sep 30, 2024 14.3B
0
Net Income
+0%
Dec 31, 2024 9.9B
Sep 30, 2024 8.4B

Earnings Waterfall
Emcure Pharmaceuticals Ltd

Revenue
124.4B INR
Cost of Revenue
-48.5B INR
Gross Profit
75.9B INR
Operating Expenses
-58.9B INR
Operating Income
17B INR
Other Expenses
-7.1B INR
Net Income
9.9B INR

Income Statement
Emcure Pharmaceuticals Ltd

Rotate your device to view
Income Statement
Currency: INR
Millions
Ones
Thousands
Millions
Billions
TTM
Quarterly
Annual
TTM
Sep-2024 Dec-2024
Revenue
Revenue
104 754
N/A
124 380
+19%
Gross Profit
Cost of Revenue
(40 672)
(48 500)
Gross Profit
64 081
N/A
75 881
+18%
Operating Income
Operating Expenses
(49 741)
(58 890)
Selling, General & Administrative
(26 193)
(29 862)
Depreciation & Amortization
(5 029)
(5 997)
Other Operating Expenses
(18 519)
(23 031)
Operating Income
14 341
N/A
16 990
+18%
Pre-Tax Income
Interest Income Expense
(2 711)
(3 100)
Total Other Income
450
489
Pre-Tax Income
12 080
N/A
14 380
+19%
Net Income
Tax Provision
(3 263)
(4 002)
Income from Continuing Operations
8 817
10 378
Income to Minority Interest
(449)
(472)
Net Income (Common)
8 368
N/A
9 906
+18%
EPS (Diluted)
44.42
N/A
52.32
+18%

See Also

Summary
EMCURE intrinsic value, competitors valuation, and company profile.
DCF Valuation
EMCURE stock valuation using Discount Cash Flow valuation method.
Relative Valuation
EMCURE stock valuation using valuation multiples.
Wall Street Estimates
EMCURE price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
EMCURE stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Follow us
Join more than 244,600+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.